The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA: A Cancer Journal for Clinicians20156528710825651787
   PubMed Web of Science ®Google Scholar
• PennathurAGibsonMKJobeBALuketichJDOesophageal carcinomaLancet2013381986440041223374478
   PubMed Web of Science ®Google Scholar
• LinYTotsukaYHeYEpidemiology of esophageal cancer in Japan and ChinaJ Epidemiol201323423324223629646
   PubMed Web of Science ®Google Scholar
• RiceTWBlackstoneEHEsophageal cancer staging: past, present, and futureThorac Surg Clin201323446146924199696
   PubMed Web of Science ®Google Scholar
• MunnLLCancer and inflammationWiley Interdiscip Rev Syst Biol Med201792e1370
   Web of Science ®Google Scholar
• GuthrieGJCharlesKARoxburghCSHorganPGMcmillanDCClarkeSJThe systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancerCrit Rev Oncol Hematol201388121823023602134
   PubMed Web of Science ®Google Scholar
• WellsGASheaBO’ConnellDThe Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses2014 Available from: www.ohrica/programs/clinical_epidemiology/oxford.aspAccessed April 25, 2017
   Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• DersimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• ZhouXLLiYQZhuWGNeutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapySci Rep201774258128195186
   PubMed Web of Science ®Google Scholar
• HeYFLuoHQWangWPreoperative NLR and PLR in the middle or lower ESCC patients with radical operationEur J Cancer Care2017262
   PubMed Web of Science ®Google Scholar
• LiuXLiMZhaoFThe lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapyOnco Targets Ther20171087187728243122
   PubMed Web of Science ®Google Scholar
• ZhangPXiMZhaoLComparison of two inflammation-based prognostic scores in patients with thoracic esophageal cancer undergoing chemoradiotherapyInt J Clin Exp Med20169217641771
   Web of Science ®Google Scholar
• ZhangFChenZWangPHuXGaoYHeJCombination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patientsTumour Biol20163779323933126779631
   PubMedGoogle Scholar
• ToyokawaTKuboNTamuraTThe pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective studyBMC Cancer20161672227599460
   PubMed Web of Science ®Google Scholar
• HiraharaNMatsubaraTMizotaYIshibashiSTajimaYPrognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomyBMC Surg20161616627650456
   PubMedGoogle Scholar
• IkeguchiMKounoYKiharaKEvaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomasMol Clin Oncol20165676777228105355
   PubMedGoogle Scholar
• GengYShaoYZhuDSystemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysisSci Rep201663948228000729
   PubMed Web of Science ®Google Scholar
• XiaoQZhangBDengXThe preoperative neutrophil-to-lymphocyte ratio is a novel immune parameter for the prognosis of esophageal basaloid squamous cell carcinomaPLoS One20161112e016829927959959
   PubMed Web of Science ®Google Scholar
• ZhuYLiMBoCPrognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinomaCancer Immunol Immunother201766334335427915370
   PubMed Web of Science ®Google Scholar
• HuangYFengJFLow preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinomaOnco Targets Ther2015813714525609981
   PubMed Web of Science ®Google Scholar
• HanLHJiaYBSongQXWangJBWangNNChengYFPrognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinomaAsian Pac J Cancer Prev20151662245225025824745
   PubMedGoogle Scholar
• JiWHJiangYHJiYLLiBMaoWMPrechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapyDis Esophagus201629540341125625421
   PubMed Web of Science ®Google Scholar
• JungJParkSYParkSJParkJPrognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinomaTumour Biol20163767149715426662960
   PubMedGoogle Scholar
• KosumiKBabaYIshimotoTNeutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patientsSurg Today201646440541326036223
   PubMed Web of Science ®Google Scholar
• ArigamiTOkumuraHMatsumotoMAnalysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and PrognosisMedicine20159442e170226496280
   PubMed Web of Science ®Google Scholar
• DuanHZhangXWangFXPrognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinomaWorld J Gastroenterol201521185591559725987784
   PubMed Web of Science ®Google Scholar
• XieXLuoKJHuYWangJYChenJPrognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancerDis Esophagus2016291798525410116
   PubMed Web of Science ®Google Scholar
• FengJFHuangYChenQXPreoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinomaWorld J Surg Oncol2014125824641770
   PubMed Web of Science ®Google Scholar
• YangYXuHZhouLPlatelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinomaClin Chim Acta201847916016529325800
   PubMed Web of Science ®Google Scholar
• SatoYGondaKHaradaMIncreased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinomaBiomed Rep201771798428685065
   PubMedGoogle Scholar
• MiaoCZhuSPanHCaoXYuanSHuXCombined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapyOncotarget2017850879718797929152134
   PubMedGoogle Scholar
• GaoGDSunBWangXBWangSMNeutrophil to lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancerInt J Biol Markers2017324409414
   Web of Science ®Google Scholar
• KijimaTArigamiTUchikadoYCombined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinomaCancer Sci2017108219319927889946
   PubMed Web of Science ®Google Scholar
• KunizakiMTominagaTWakataKClinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinomaMol Clin Oncol20188237037429435305
   PubMed Web of Science ®Google Scholar
• YangXHuangYFengJFLiuJSPrognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysisOnco Targets Ther2015878979425914549
   PubMed Web of Science ®Google Scholar
• YodyingHMatsudaAMiyashitaMPrognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysisAnn Surg Oncol201623264665426416715
   PubMed Web of Science ®Google Scholar
• HuangYSunYPengPZhuSSunWZhangPPrognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysisOnco Targets Ther2017101165117228260931
   PubMed Web of Science ®Google Scholar
• ZhaoQTZhangXPZhangHDuanGCPrognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysisOncotarget201786711208511209329340113
   PubMedGoogle Scholar
• GülgünMMethodology, as well as physiological and pathological conditions, can affect analysis of the lymphocyte-to-monocyte ratioRev Port Cardiol201736432328343789
   PubMedGoogle Scholar
• WangSXiaoTHuCAre preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio prognostic factors for patients with esophageal squamous cell cancer?Dis Esophagus201629670425833202
   PubMed Web of Science ®Google Scholar